Representatives of several small and medium pharma companies have suggested that the government adopt a "one molecule-one MRP" formula instead of trade margin rationalisation (TMR) on non-scheduled drugs to reduce their prices.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vHqFJfZ
via IFTTT
0 comments:
Post a Comment